Linscomb Wealth Inc. lessened its stake in shares of The Allstate Corporation (NYSE:ALL – Free Report) by 8.7% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,723 shares of the insurance provider’s stock after selling 356 shares during the period. Linscomb Wealth Inc.’s holdings in Allstate were worth $750,000 at the end of the most recent reporting period.
A number of other hedge funds have also recently added to or reduced their stakes in ALL. Price T Rowe Associates Inc. MD increased its stake in Allstate by 25.4% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 11,709,610 shares of the insurance provider’s stock worth $2,424,710,000 after acquiring an additional 2,374,684 shares during the period. Boston Partners increased its stake in shares of Allstate by 613.9% in the 1st quarter. Boston Partners now owns 2,482,654 shares of the insurance provider’s stock valued at $512,627,000 after purchasing an additional 2,134,893 shares during the last quarter. Goldman Sachs Group Inc. increased its stake in shares of Allstate by 27.2% in the 1st quarter. Goldman Sachs Group Inc. now owns 2,328,070 shares of the insurance provider’s stock valued at $482,073,000 after purchasing an additional 497,982 shares during the last quarter. Strs Ohio acquired a new position in shares of Allstate during the 1st quarter worth $84,408,000. Finally, AQR Capital Management LLC raised its holdings in shares of Allstate by 20.3% during the 1st quarter. AQR Capital Management LLC now owns 2,018,403 shares of the insurance provider’s stock worth $417,244,000 after buying an additional 340,150 shares in the last quarter. Institutional investors own 76.47% of the company’s stock.
Analyst Upgrades and Downgrades
ALL has been the subject of a number of research analyst reports. Wolfe Research raised Allstate to a “strong-buy” rating in a report on Tuesday, September 16th. Wall Street Zen raised Allstate from a “buy” rating to a “strong-buy” rating in a report on Saturday, October 25th. UBS Group boosted their price target on Allstate from $235.00 to $250.00 and gave the stock a “buy” rating in a report on Wednesday, October 8th. Weiss Ratings reissued a “buy (b)” rating on shares of Allstate in a report on Wednesday, October 8th. Finally, Morgan Stanley boosted their price target on Allstate from $235.00 to $245.00 and gave the stock an “overweight” rating in a report on Friday, August 1st. Two analysts have rated the stock with a Strong Buy rating, twelve have issued a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $234.27.
Allstate Price Performance
Allstate stock opened at $191.71 on Friday. The company has a current ratio of 0.43, a quick ratio of 0.43 and a debt-to-equity ratio of 0.37. The company has a market capitalization of $50.52 billion, a PE ratio of 9.01, a P/E/G ratio of 0.69 and a beta of 0.38. The Allstate Corporation has a 12 month low of $176.00 and a 12 month high of $215.70. The stock has a 50-day moving average price of $202.56 and a two-hundred day moving average price of $201.02.
Allstate (NYSE:ALL – Get Free Report) last posted its earnings results on Wednesday, July 30th. The insurance provider reported $5.94 EPS for the quarter, beating the consensus estimate of $3.20 by $2.74. The firm had revenue of $15.05 billion during the quarter, compared to the consensus estimate of $16.59 billion. Allstate had a return on equity of 28.74% and a net margin of 8.79%.The business’s quarterly revenue was up 5.8% on a year-over-year basis. During the same period last year, the company earned $1.61 earnings per share. Analysts expect that The Allstate Corporation will post 18.74 EPS for the current year.
About Allstate
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Read More
- Five stocks we like better than Allstate
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Amazon Earnings: 3 Catalysts That Could Drive Shares to $300
- Large Cap Stock Definition and How to Invest
- Why Chipotle Stock May Bounce After a Brutal Sell-Off
- How to trade using analyst ratings
- Why VGT May Be a Smarter Bet Than Chasing Individual Tech Stocks
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Corporation (NYSE:ALL – Free Report).
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.
